Unichem Laboratories rose 3.09% to Rs 175.20 after the company said its Pithampur plant was approved by the US drug regulator after successful inspection.
The United States Food and Drug Administration (USFDA) conducted inspection at the company's Active Pharmaceutical Ingredients (APls) facility in Pithampur, Madhya Pradesh from 2 to 5 September 2019. The inspection concluded successfully without any FDA form 483. The announcement was made during market hours today, 6 September 2019.
On BSE, 4,918 shares were traded in Unichem Laboratories counter, compared to a 2-week average of 13,000 shares. The stock hit an intraday high of Rs 178.65 and an intraday low of Rs 169.80.
It hit a 52-week high of Rs 239.75 on 10 September 2018 and a 52-week low of Rs 158.35 on 31 July 2019.
Unichem Laboratories is a pharmaceutical company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app